1040 GMT July 06, 2022
Iran’s COVID-19 infections, hospitalizations and deaths have gradually been declining over the past few days, said the head of the Health Ministry’s Center for Disease Control and Prevention.
Speaking in a televised interview, Dr. Mohammad Mehdi Gooya added the declining trend, however, is not reflected evenly by all provinces, IRNA reported.
He gave the assurance, however, that within the next few days the majority of the provinces will regain partial calm.
Gooya noted that, at present, the situation regarding the COVID-19 pandemic is the most challenging in the western provinces, urging greater care and attention to curb the coronavirus spread.
He announced that vaccination of the people aged over 30 has already begun in the country, noting that younger people’s inoculation is on the Health Ministry’s agenda.
Iran’s public vaccination process has gained greater momentum over the past few weeks in view of the rise in imports and domestic production of vaccines, setting new daily records.
The country has received several COVID-19 vaccine batches from Russia (Sputnik V), China (Sinopharm), Japan (AstraZeneca) and India (COVAXIN), and has also developed a number of COVID jabs domestically, including one dubbed COVIran Barekat (Barakat Foundation), a jab named Soberana 2, or PastoCoVac (Cuba’s Instituto Finlay de Vacunas and Iran’s Pasteur Institute) and a vaccine known as Fakhra (Defense Ministry).
The other two COVID jabs being developed in the country are Noura (the Islamic Revolution Guards Corps) and Razi Cov Pars (Razi Vaccine and Serum Research Institute).
According to figures by the Islamic Republic of Iran Customs Administration, Sinopharm accounts for the biggest share (37,529,596 doses) of the country’s jab purchases.
Iran’s Health Ministry announced in a statement on Sunday that the country’s daily COVID-19 deaths and infections reached 391 and 15,975, respectively, in the past 24 hours.
The statement added the total COVID-19 death toll and infections since the beginning of the outbreak in the country in late February 2020 stand at 117,182 and 5,424,835, respectively.
The ministry said, 6,765 COVID-19 patients are in critical condition, and of the newly-detected cases, 2,207 individuals have been hospitalized.
It added 4,764,998 COVID-19 patients have so far either recovered from the disease or have been discharged from hospitals.
The statement added 31,007,134 coronavirus diagnostic tests have so far been carried out in the country and 43,372,270 doses of COVID-119 vaccines have been administered.
The Health Ministry said 57 cities in the country are coded red (very high-risk), while 238 are in the orange zone (high-risk).
The number of the country’s yellow (medium-risk) and blue (low-risk) cities are 136 and 17, respectively, according to the ministry.
Iran has been grappling with a fifth wave of the COVID-19 pandemic since a few weeks ago, mainly sparked by the spread of the Indian coronavirus variant, known as Delta, seeing a resurgence in deaths and infections.